References
- Dören M, Reuther G, Minne H W, Schneider H P. Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. Am J Obstet Gynecol 1995; 173: 1446–51
- Hill D A, Weiss N S, LaCroix A Z. Adherence to postmenopausal hormone therapy during the year after the initial prescription: a population study. Am J Obstet Gynecol 2000; 182: 270–6
- Riphagen F E. Intrauterine application of progestins in hormone replacement therapy: a review. Climacteric 2000; 3: 199–211
- MacLennan A H. The four harms of harmless therapies. Climacteric 1999; 2: 73–4
- MacLennan A H. Advertising standards for complementary medicines at the climacteric. Climacteric 2000; 3: 81–3
- Knight D C, Howes J B, Eden J A. The effect of Promensil®, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2: 79–84
- Baber R J, Templeman C, Morton T, Kelly G E, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999; 2: 85–92
- Ginsburg J, Prelevic G M. Is there a proven place for phytoestrogens in the menopause?. Climacteric 1999; 2: 75–8
- Kotsopoulos D, Dalais F S, Liang Y-L, McGrath B P, Teede H J. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric 2000; 3: 161–7
- Lee J. Osteoporosis reversal: the role of progesterone. Int Clin Nutr Rev 1990; 10: 384–9
- Wren B G, McFarland K, Edwards L, O'Shea P, Sufi S, Gross B, Eden J. Effect of sequential trans-dermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000; 3: 155–60